Delivery Order SPE2DR25D3103-SPE2DR26F0A5A
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,721.90 to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price delivery order includes no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,062.50 to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials. This competitively awarded, firm fixed-price delivery order was issued on January 27, 2026, with an ultimate completion date of January 28, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child task order under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant...
- The Defense Logistics Agency awarded a delivery order valued at $8,741.22 to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with performance completion scheduled for September 17, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials with a ceiling value of $10,669.20. The delivery order, which was competitively awarded without set-aside designations, is scheduled for completion by November 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. This award represents a child contract action executed under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Abraxane 100 mg vials valued at $7,565.23. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $16,261.46 to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with an ultimate completion date of November 21, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger contract vehicle with the DLA. The pharmaceutical product will be delivered to the company's Conshohocken, Pennsylvania location, which serves as the...
- The Defense Logistics Agency awarded a $8,853.94 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Abraxane 100 mg vials, with an ultimate completion date of August 27, 2025. This contract employs firm fixed price terms and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor, for the provision of ABRAXANE 100 MG VIALS. The contract has a potential value of $8,837.51 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563188797 ABRAXANE 100 MG VIALS. The order, valued at $16,981.70, has a completion date of December 28, 2023. Amerisourcebergen Drug Corp, a for-profit organization, provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order is part of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Abraxane, a chemotherapy medication, with a ceiling value of $13,026.68. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by December 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This delivery order falls...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F0A5ADelivery Order
The Defense Logistics Agency awarded a $11,033.72 firm fixed-price delivery order to Amerisourcebergen Drug Corp (a subsidiary of parent company Cencora, Inc.) on January 27, 2026, for the supply of Abraxane 100 mg vials. The contract, which serves as a delivery order under a larger vehicle, will be completed by January 28, 2026, with performance at the vendor's Conshohocken, Pennsylvania location. This award was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open competition. Amerisourcebergen Drug Corp operates as a major pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order falls under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, vaccines, and specialized medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 1/26/26 |